Multiple-cytokine-producing CD30-positive diffuse large B-cell lymphoma.
Nakayama-Ichiyama
Shoko
S
Yokote
Taiji
T
Oka
Satoko
S
Iwaki
Kazuki
K
Kobayashi
Kichinosuke
K
Akioka
Toshikazu
T
Hiraoka
Nobuya
N
Takayama
Ayami
A
Takubo
Takayuki
T
Tsuji
Motomu
M
Hanafusa
Toshiaki
T
D000368:Aged; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D058846:Antibodies, Monoclonal, Murine-Derived; D015703:Antigens, CD / Q000032:analysis; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001402:B-Lymphocytes / Q000737:chemistry* / Q000473:pathology; D002097:C-Reactive Protein / Q000032:analysis; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D016130:Immunophenotyping; D015850:Interleukin-6 / Q000097:blood / Q000378:metabolism*; D017730:Ki-1 Antigen / Q000032:analysis*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000097:blood / Q000737:chemistry / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery; D008297:Male; D011239:Prednisolone / Q000008:administration & dosage; D000069283:Rituximab; D013156:Splenectomy; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis / Q000378:metabolism*; D014750:Vincristine / Q000008:administration & dosage
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D015703:Antigens, CD; C508600:IL6 protein, human; D015850:Interleukin-6; D017730:Ki-1 Antigen; D014409:Tumor Necrosis Factor-alpha; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D002097:C-Reactive Protein; D011239:Prednisolone